AgeneBio Secures $1,000,113 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b39532e6-75a0-40ae-a5d9-45a231879354
Date
11/19/2013
Company Name
AgeneBio
Mailing Address
11711 North Meridian Street Carmel, IN 46032
Company Description
AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s disease (AD).
Website
http://www.agenebio.com
Transaction Type
Venture Equity
Transaction Amount
$1,000,113
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed